Back to search

Switzerland· 67746002

Tacrocutan 1 mg/g, Salbe

A tacrolimus product containing tacrolimusum, rrr-alpha-tocopherolum, registered in Switzerland by Dermapharm AG and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 12 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC D11AH01

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedTacrocutan 1 mg/g, SalbeATCD11AH01REGISTER NO.67746002PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Tacrolimus is registered in 12 of 19 countries.

Countries holding a registration under ATC D11AH01 (tacrolimus), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 8 of them publish a price we can compare per daily dose

Tacrolimus · ATC D11AH01

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Swissmedic (Switzerland)
Active substance
tacrolimusum, RRR-alpha-tocopherolum
Manufacturer
Dermapharm AG
Country
Switzerland (CH)
ATC code
D11AH01
ATC class
Tacrolimus
Swissmedic category
B
Reimbursed
Yes
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680677460029
    Tb 30 g
    CHF 40.05

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/262ba99f-f5a0-4ffe-9175-97924d586e34
GET /v1/drugs/262ba99f-f5a0-4ffe-9175-97924d586e34?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "tacrolimusum 1 mg",
  "valid_from": "2024-10-01",
  "limitations": "[{\"description\":\"Zur Behandlung mittelschwerer bis schwerer atopischer Dermatitis, falls die herkömmliche Behandlung nicht genügend wirksam ist oder Nebenwirkungen auftreten.\",\"costApproval\":null,\"indication\":\"\",\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2024-10-01\"}]",
  "galenic_form": "Salbe 0.1 %",
  "therapeutic_area": null,
  "sl_inclusion_date": "2024-10-01",
  "self_retention_pct": 10
}

See everything about tacrolimus.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.